Russell Investments Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,692
| Closed | -$1.66M | – | 2983 |
|
|
2021
Q4 | $1.66M | Buy |
10,692
+5,999
| +128% | +$934K | ﹤0.01% | 1900 |
|
|
2021
Q3 | $940K | Buy |
4,693
+1,039
| +28% | +$208K | ﹤0.01% | 2219 |
|
|
2021
Q2 | $932K | Sell |
3,654
-1,463
| -29% | -$373K | ﹤0.01% | 2346 |
|
|
2021
Q1 | $1.36M | Buy |
5,117
+2,991
| +141% | +$793K | ﹤0.01% | 2105 |
|
|
2020
Q4 | $783K | Sell |
2,126
-123
| -5% | -$45.3K | ﹤0.01% | 2232 |
|
|
2020
Q3 | $548K | Buy |
2,249
+1,426
| +173% | +$347K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $237K | Buy |
823
+311
| +61% | +$89.6K | ﹤0.01% | 2670 |
|
|
2020
Q1 | $104K | Buy |
+512
| New | +$104K | ﹤0.01% | 2722 |
|
|
2017
Q1 | – | Sell |
-183
| Closed | -$60K | – | 3101 |
|
|
2016
Q4 | $60K | Buy |
+183
| New | +$60K | ﹤0.01% | 2955 |
|